Objectives-To examine the mortality pattern and the cancer incidence in a cohort of long term smelter workers exposed to lead. Methods-The cohort consists of 664 male lead battery workers, employed for at least three months in 1942-87. From 1969 the values of all blood lead samples repeatedly obtained from these workers every two to three months, have been collected in a database. The expected mortality and morbidity 1969-89 was estimated from the county rates, specified for cause, sex, five-year age groups, and calendar year. Individual exposure matrices have been calculated and used for dose-response analyses. Results-The total cohort showed an increased overall mortality standardizedd mortality ratio (SMR) 1*44; 95% confidence interval (95% CI) 1.16-1.79), an increased mortality from ischaemic heart diseases (SMR 1*72; 95% CI 1-20-2.42) and all malignant neoplasms (SMR 1-65; 95% CI 1-09-2-44). These risk estimates were unaffected or slightly decreased when applying a latency period of 15 years, and no dose-response pattern was shown. The non-significantly raised cancer incidence in the gastrointestinal tract (11 malignancies) in the total cohort, increased to a barely significant level in the quartile with the highest cumulative lead exposure (standardised incidence ratio (SIR) 2*34, 95% CI 1-07-4.45). No clear dose response pattern was evident when further subdividing the data into those first employed up to 1969 v those first employed after 1969 when the blood lead monitoring programme started. The risk estimate for malignancies in the gastrointestinal tract was not related to latency time. The cancer incidence was not increased at other sites. Conclusions-A slightly increased incidence of gastrointestinal cancers was found in workers exposed to lead and employed before 1970. The lead cohort also showed an increased mortality from ischaemic heart diseases. These risk estimates did not show a dose-response pattern and were not associated with latency time. The results must also be interpreted with caution because of limited numbers, and lack of dietary and smoking data.
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(Occup Environ Med 1995;52:667-672) Keywords: inorganic lead; gastrointestinal malignancies; ischaemic heart diseases; lead smelter workers Several animal experiments have shown a tumorigenic effect of lead. Soluble lead salts such as lead acetate and lead subacetate have produced kidney and brain tumours, and lead phosphate kidney tumours in rodents after oral or parenteral administration. 6 The development of malignancies mostly occurred in rats at very high exposures, for example about 10 000 ppm of soluble lead in food or drinking water. Thus, these effects seem to take place at doses that are close to the maximum tolerable dose and well above the dose that is acutely toxic to the target organ.7 Synergistic effects for the development of cancer between lead acetate and lead oxide and some organic carcinogens, such as benzo(a)pyrene and nitrosoamines have also been reported.5 Sufficient data are not available for a proper evaluation of metallic lead, lead oxide, and lead tetraalkyls.
A few case reports of kidney cancer in workers exposed to lead have been presented.89 In a study in Finland of work related kidney cancer (adenocarcinomas), there was a non-significantly increased risk related to lead exposure.'0 In general, the epidemiological studies undertaken do not support a carcinogenic effect of inorganic lead in humans, although the exposure in several studies has been rather high (> 3 0,umol/l blood). Small excess risks have been found in a few studies, but they could be attributed to confounding factors. In 1987, the International Agency for Research on Cancer (IARC) concluded that the evidence for carcinogenicity of lead in humans was insufficient. 5 The disagreement between epidemiological studies and animal experiments could be due to differences in exposures or to differences in species sensitivity. Doses given in experiments may be more than 1000-fold higher than permissible exposure limits in different countries. Exposures of that magnitude would send a hypothetical lead worker to the hospital within days or weeks.7 Considerable differences exist between rats and hamsters or dogs. It is plausible that such differences also exist between rats and humans, which complicates extrapolation of results from animal experiments. Nevertheless, further studies are needed to clarify the concern about human carcinogenicity of lead.
The aim of the present study was to assess the mortality pattern and the cancer incidence among workers exposed to lead from a Gerhardsson, Hagmar, Rylander, Skerlving secondary smelter without any concomitant occupational exposure to lung carcinogens such as arsenic, cadmium, chromium, and nickel and with limited exposure to polycyclic aromatic hydrocarbons (PAHs).
Materials and methods

THE PLANT AND LEAD PRODUCTION
The secondary lead smelter in southern Sweden was started in 1942. The production of inorganic lead has been between 37 000 and 40 000 tonnes a year during the 1990s. During the 1950s the production was lower, about 10 000 tonnes a year, and during the 1960s-1980s about 30 000 tonnes a year. Also, the company has an annual tin production of about 2000 tonnes.
The raw materials for lead and lead alloys are obtained from different sources. Scrap lead from telephone cables and old car, bus, and lorry batteries forms the largest single group of raw materials. Other sources include lead ashes from rubber companies, iron works, and glassworks, where lead is used to impart a beautiful lustre to crystal. The raw materials are mixed in a large blast furnace, producing blocks of raw lead weighing about 2700 kg.
These are transported to the refining section and converted into new, high grade metal and metal alloys in the form of ingots. The products consist primarily of various types of lead-antimony alloys for car batteries, cables, and ammunition, as well as pure unalloyed lead for the rubber industry, among others.
There have been between 150 and 160 workers during most of the follow up period (see later section). Due been less than 5%. The detection limit has been about 0 05 ,umol/l (10 pug/l).
Since 1971, the laboratory has participated in a Nordic calibration programme between laboratories and the accuracy has been tested twice every year. The results during the study period have agreed well with the expected concentrations.'2 Since 1983, the laboratory has participated in the United Kingdom external quality assessment scheme. The results have consistently been in good agreement with expected concentrations (95% of measurements < ± 5%; 5% of measurements 5%-20%). The quality control series have not displayed any time trends.
Before 1973 a colourimetric method was used for blood lead determinations, after extraction with dithizone in chloroform. The ashing procedure and the set up of blanks, standards, and samples was the same as for the flame AAS method. A separation step involving precipitation of lead with calcium phosphate from a solution containing oxalate of about pH 5 was used to eliminate colourimetric disturbances from iron in the chloroform dithizone extract.
Potassium cyanide was added to the ammonia citric acid buffer solution to avoid interferences from-for example, cadmium, copper, and zinc. The detection limit of this method was 0-05 ,umol/l. During a transition period of about one year both methods were used in parallel. The values obtained by the colourimetric method were somewhat higher (mean V-V (SD) 105% (5-8%); n = 24) in the concentration range 0-3-1 9,umol/l, although there was no difference (100% (4-8%); n = 34) between the methods at blood lead concentrations
In 1969, when the blood lead sampling programme started, 201 male smelter workers exposed to lead were employed at the plant, and had been so for at least three months. The 463 male workers who were employed for at least three months in 1970-89 were also included in the cohort. For 60 workers, date of both start and end of employment were unknown and they were therefore not included in the cohort. Moreover, 21 workers of Danish origin were also not included in the cohort, as they could not be tracked down in the Swedish population register. The Restricting the analysis to the quartile of workers with the highest cumulative lead dose, the SIR for gastrointestinal cancer was increased (SIR 2-34; 95% CI 1 07-445) compared with the total cohort. As was the case for the total cohort, the information available in the highest exposed quartile almost totally originates from the subcohort first employed up to 1969. Among those employed up to 1969, the SIRs were not affected by cumulative exposure to lead, or by applying latency periods of 10 or 15 years (table 3) . Thus, the increased risk estimate for gastrointestinal malignancies was related to employment before 1970 and not to dose or latency time. The results were similar when exposure intensity over time or peak blood lead concentrations > 3.4,umol/l were used instead of cumulative lead dose as the exposure variable. Discussion An increased total mortality, and more specifically an increased mortality from ischaemic heart diseases and all malignant neoplasms, was found among the workers exposed to lead. No dose-response pattern was found and the risk estimates did not increase when a latency period of 15 years was applied.
An increased incidence of gastrointestinal malignancies was found among the workers exposed to lead. This tendency was related to employment before 1970 and not to lead dose or to latency time.
ASPECTS OF VALIDITY
The size of this cohort is limited as was the observed number of deaths and incident malignancies. Thus, the statistical power to detect an increased mortality or morbidity for different site specific malignancies was rather low. On the other hand, the present study design allowed a fairly good individual lead dose estimate, based on blood samples drawn every two to three months since 1969. For some lead workers this index is based on about 170 blood lead samples. The lead exposure has been evaluated in terms of total blood lead dose during the time of employment at the smelter, as well as peak blood lead concentrations exceeding 3 4,umol/l, and exposure intensity over time. These comparisons gave similar results indicating a slightly increased cancer incidence in the gastrointestinal tract in workers exposed to lead. These risk estimates were not related to dose or latency time.
Most of the workers at the smelter had been exposed to inorganic lead for many years and there had been no concomitant exposure to other potentially carcinogenic metals such as arsenic, hexavalent chromium, nickel, and cadmium, which is common in primary smelters.'3 '-There has been some exposure to antimony, which makes up about 3 5% (mean) of the produced lead ingots. No determinations of antimony in air have been performed at the smelter. Exposure to combustion gases that may contain organic Table 2 Tumour morbidity (observed and expected) in the total cohort of workers exposed to lead in comparison with the county population, during thefollow up period 1969 carcinogens (PAHs) has been limited, as has exposure to irritating gases such as sulphur dioxide.
In Sweden, more reliable information on tumours is gained from incidence data from the Swedish Cancer Registry, in comparison with the Cause of Death Registry.'8 Thus, the morbidity figures in tables 2 and 3 would have a higher validity than cancer mortality data presented in this study.
For workers employed at the smelter before 1969, their previous lead exposure has been estimated on their exposure during 1969. As the airborne exposure at the smelter has decreased over the years in parallel with improvement of exhaust ventilation, repeated reconstruction and modernisation of the processes, as well as increased use of breathing protective devices (figure), the accumulated lead exposure for these workers has probably been somewhat underestimated.
GASTROINTESTINAL MALIGNANCIES
In a recent meta-analysis of case control and cohort studies of people exposed to lead, the combined results from 10 studies showed a significant excess risk of stomach cancer, relative risk (RR) = 1-33 (95% CI 1-18-1-49 An increased mortality from cardiovascular diseases has been found in several epidemiological studies of lead workers. These enhanced risks refer mainly to cerebrovascular diseases.202' 2327 Furthermore, excessive deaths from hypertensive diseases have been found in battery plant and lead production workers."3 Other studies have been negative.'4 15 The interpretation of these studies is hampered by lack of data on smoking.
It has been indicated that there is an increase of systolic and diastolic blood pressure by 1-2 mm Hg for each doubling of blood lead, in the blood lead range in the general population.28 Several mechanisms for this have been discussed-for example, a direct lead action on vascular smooth muscle, as well as renal effects mediated through the renin-angiotensin system.29 Lead may also alter renal vascular reactivity to a-adrenergic agents.30 Also, direct cardiovascular effects may occur. 29 Thus, a lead effect on blood pressure may contribute to the increased mortality from cerebrovascular deaths reported in some studies,20 21 23 27 and possibly also to other cardiovascular deaths. 29 In accordance with this theory, the mortality from ischaemic heart diseases was raised in the present cohort. The SMR did not increase with increasing lead dose or when a Gerhardsson, Hagmar, Rylander, Skeriing latency period of 10 or 15 years was applied. The interpretation is complicated by lack of data on smoking.
Conclusion
A slightly increased incidence of gastrointestinal malignancies in lead workers employed before 1970, as well as an increased mortality from ischaemic heart diseases, was indicated in this study. The risk estimates did not show a dose-response pattern and were not associated with latency time. The results must also be interpreted with caution because of limited numbers, and lack of information on dietary and smoking habits. Most epidemiological studies about the relation between exposure to inorganic lead and the development of malignancies have been negative. Small excess risks in some studies could be explained by confounding factors and are often difficult to evaluate because of lack of individual exposure data on cumulative lead exposure. The animal experimental findings and the increased risks indicated in some studies, especially for stomach, lung, and bladder cancer in a recent meta-analysis'9 still keeps the question of human carcinogenicity on the agenda. 
